If it was confirmed that harmful effects take longer to emerge, it might be appropriate to offer older people prescribed aspirin more frequent eye examinations, given the potential to prevent rapid visual loss from wet AMD with anti-Vascular Endothelial Growth Factor (VEGF) therapies. Here, VEGFA is linked to wet macular degeneration.